MTL Cannabis (DB:J4E) - Stock Price, News & Analysis

J4E Stock Overview

Through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada. More details

J4E fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	3/6
Financial Health	1/6
Dividends	0/6

Rewards

Trading at 98.7% below our estimate of its fair value

Became profitable this year

Risk Analysis

Interest payments are not well covered by earnings

Highly volatile share price over the past 3 months compared to the German market

Does not have a meaningful market cap (€22M)

MTL Cannabis Corp. Competitors

Pierrel

DB:2FJ0

€92.8m

MPH Health Care

DB:93M1

€105.3m

PharmaSGP Holding

XTRA:PSG

€280.6m

Dermapharm Holding

XTRA:DMP

€2.0b

Price History & Performance

Summary of all time highs, changes and price drops for MTL Cannabis
Historical stock prices
Current Share Price	CA$0.10
52 Week High	CA$0.46
52 Week Low	CA$0.067
Beta	0
11 Month Change	29.87%
3 Month Change	16.28%
1 Year Change	-66.44%
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-53.70%

Recent updates

Shareholder Returns

	J4E	DE Pharmaceuticals	DE Market
7D	28.2%	-1.2%	-0.02%
1Y	-66.4%	-20.1%	8.2%

Return vs Industry: J4E underperformed the German Pharmaceuticals industry which returned -20.1% over the past year.

Return vs Market: J4E underperformed the German Market which returned 8.2% over the past year.

Price Volatility

Is J4E's price volatile compared to industry and market?
J4E volatility
J4E Average Weekly Movement	24.0%
Pharmaceuticals Industry Average Movement	6.9%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	10.9%
10% least volatile stocks in DE Market	2.3%

Stable Share Price: J4E's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: J4E's weekly volatility has decreased from 31% to 24% over the past year, but is still higher than 75% of German stocks.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Mike Perron	www.mtlcannabis.ca

MTL Cannabis Corp., through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada. The company offers dried flower, pre-rolls, and hash products. It also operates clinics that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from medical conditions.

MTL Cannabis Corp. Fundamentals Summary

How do MTL Cannabis's earnings and revenue compare to its market cap?
J4E fundamental statistics
Market cap	€15.27m
Earnings (TTM)	€3.33m
Revenue (TTM)	€50.33m

4.6x

P/E Ratio

0.3x

P/S Ratio

Is J4E overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
J4E income statement (TTM)
Revenue	CA$73.25m
Cost of Revenue	CA$32.60m
Gross Profit	CA$40.65m
Other Expenses	CA$35.81m
Earnings	CA$4.84m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.041
Gross Margin	55.50%
Net Profit Margin	6.61%
Debt/Equity Ratio	127.4%

How did J4E perform over the long term?

See historical performance and comparison

MTL Cannabis DB:J4E Stock Report